Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | $44.69B | — | $0 | — | -$1.13B | $815.44M | $154.49M | Overvalued |
| VEEVVeeva Systems Inc | $44.65B | 45.4× | $3.2B | +16.3% | $908.91M | $1.81B | $151.7M | Overvalued |
| KDPKeurig Dr Pepper Inc. | $44.45B | 33.1× | $16.6B | +8.2% | $2.08B | $1.52B | $32.17B | Fair valued |
| FERGFerguson Enterprises Inc. | $44.34B | 20.5× | $12.83B | -58.3% | $786M | $437M | $6.89B | Overvalued |
| IQVIqvia Holdings Inc. | $44.17B | 33.3× | $16.31B | +5.9% | $1.36B | $1.95B | $16.07B | Fair valued |
| WDSWoodside Energy Group Ltd | $44.04B | 14.2× | $12.98B | -1.5% | $2.74B | $5.71B | $13.72B | Fair valued |
| KBKB Financial Group Inc. | $43.99B | 11.0× | ₩11.02T | -32.1% | ₩5.03T | ₩24.61T | ₩11.47T | Fair valued |
| CCJCameco Corp | $43.82B | 175.4× | CA$3.48B | +11.0% | CA$589.54M | CA$1.11B | CA$1.01B | Overvalued |
| PAYXPaychex Inc | $43.73B | 25.1× | $6.3B | +16.5% | $1.76B | $1.09B | $4.63B | Fair valued |
| HMCHonda Motor Co Ltd | $42.89B | — | ¥21.69T | +6.2% | ¥903.03B | ¥4.53T | ¥11.77T | Undervalued |
| CBRECbre Group, Inc. | $42.69B | 33.8× | $39.9B | +13.4% | $1.16B | $1.49B | $10.81B | Overvalued |
| AAgilent Technologies, Inc. | $42.65B | 29.8× | $6.95B | +6.7% | $1.3B | $1.76B | $4.15B | Overvalued |
| TEVATeva Pharmaceutical Industries Ltd | $42.56B | 62.0× | $17.26B | +4.3% | $1.41B | $3.66B | $4.78B | Fair valued |
| HLNHaleon plc | $42.54B | 19.8× | £11.03B | -1.8% | £1.68B | £1.32B | £8.61B | Fair valued |
| PRUPrudential Financial Inc | $42.51B | 11.2× | $60.77B | -13.7% | $3.58B | $15.16B | $20.62B | Fair valued |
| IXOrix Corp | $42.46B | 11.1× | ¥1.5T | +11.2% | ¥447.27B | ¥1.33T | ¥6.81T | Fair valued |
| GFIGold Fields Ltd | $42.3B | 9.8× | $5.2B | +15.6% | $1.29B | $860.2M | $2.95B | Fair valued |
| AXONAxon Enterprise, Inc. | $42.17B | 215.0× | $2.78B | +33.5% | $124.66M | $597.7M | $1.83B | Overvalued |
| IDXXIdexx Laboratories Inc | $41.95B | 37.4× | $4.3B | +10.4% | $1.06B | $196.93M | $577.08M | Overvalued |
| FERFerrovial N.V. | $41.77B | 60.7× | €9.63B | +5.2% | €1.15B | €4.27B | €10.73B | Overvalued |